| Meredith Cromer, FNP-BC | |
|
1115 Blanton Dr, Sevierville, TN 37862 | |
| (865) 453-4434 | |
| (866) 610-2903 |
| Full Name | Meredith Cromer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1115 Blanton Dr, Sevierville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023436326 | NPI | - | NPPES |
| Q008455 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 18538 (Tennessee) | Primary |
| Entity Name | Eastlake Medical, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467992446 PECOS PAC ID: 6901174788 Enrollment ID: O20170620001620 |
News Archive
Roche released the following statement in response to a report issued by Institutional Shareholder Services recommending that shareholders of Illumina, Inc. vote against the election of Roche's independent director nominees to Illumina's Board of Directors.
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
AstraZeneca and Pharmacyclics, Inc. today announced that they have entered into a clinical trial collaboration to evaluate a novel combination therapy targeting solid tumors.
This was supposed to be a big health care year for California.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meredith Cromer, FNP-BC Po Box 15004, Knoxville, TN 37901-5004 Ph: (865) 541-8895 | Meredith Cromer, FNP-BC 1115 Blanton Dr, Sevierville, TN 37862 Ph: (865) 453-4434 |
News Archive
Roche released the following statement in response to a report issued by Institutional Shareholder Services recommending that shareholders of Illumina, Inc. vote against the election of Roche's independent director nominees to Illumina's Board of Directors.
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
AstraZeneca and Pharmacyclics, Inc. today announced that they have entered into a clinical trial collaboration to evaluate a novel combination therapy targeting solid tumors.
This was supposed to be a big health care year for California.
› Verified 3 days ago
Mrs. Maggie Elline Keck, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 415 Catlett Rd, Sevierville, TN 37862 Phone: 865-330-7425 Fax: 865-333-5848 | |
Phyliss A. Shults, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 641 Middle Creek Rd, Sevierville, TN 37862 Phone: 865-428-0583 Fax: 865-428-1625 | |
Jessica Williams Cooper, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 215 Forks Of The River Pkwy, Sevierville, TN 37862 Phone: 865-366-4070 Fax: 865-366-3720 | |
Jordan E Mccroskey, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 675 Middle Creek Rd, Sevierville, TN 37862 Phone: 865-453-2039 Fax: 833-908-2175 | |
Rhonda Levada Daniels-reinalda, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1787 Veterans Blvd Ste 101, Sevierville, TN 37862 Phone: 865-428-2773 | |
Mrs. Jessica Breedlove, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 470 Collier Dr, Sevierville, TN 37862 Phone: 865-286-5421 |